BIOTIME (BTX)

	SUMMARY

	BULLS

	BEARS

	DATA CENTRAL

	STOCK CHART

	SEC FILINGS

	BALANCE

	INCOME

	CASH FLOW

Annual Reports

Quarterly Reports

8-K

8-K (Apr 10, 2013)8-K (Mar 25, 2013)8-K (Mar 21, 2013)8-K (Mar 18, 2013)8-K (Mar 13, 2013)8-K (Mar 12, 2013)8-K (Mar 7, 2013)8-K (Mar 4, 2013)8-K (Feb 11, 2013)8-K (Jan 31, 2013)8-K (Jan 30, 2013)8-K (Jan 18, 2013)8-K (Jan 10, 2013)8-K (Jan 9, 2013)8-K (Jan 8, 2013)8-K (Jan 7, 2013)8-K (Dec 21, 2012)8-K (Dec 20, 2012)8-K (Dec 18, 2012)8-K (Dec 14, 2012)8-K (Dec 6, 2012)8-K (Dec 4, 2012)8-K (Nov 29, 2012)8-K (Nov 27, 2012)8-K (Nov 20, 2012)8-K (Nov 19, 2012)8-K (Nov 15, 2012)8-K (Nov 14, 2012)8-K (Nov 9, 2012)8-K (Nov 7, 2012)8-K (Nov 1, 2012)8-K (Oct 23, 2012)8-K (Oct 19, 2012)8-K (Oct 4, 2012)8-K (Sep 28, 2012)8-K (Sep 19, 2012)8-K (Aug 27, 2012)8-K (Aug 16, 2012)8-K (Aug 9, 2012)8-K (Aug 1, 2012)8-K (Jul 26, 2012)8-K (Jul 17, 2012)8-K (Jun 29, 2012)8-K (Jun 4, 2012)8-K (May 23, 2012)8-K (May 22, 2012)8-K (May 21, 2012)8-K (May 14, 2012)8-K (May 10, 2012)8-K (Apr 25, 2012)8-K (Apr 23, 2012)8-K (Apr 20, 2012)8-K (Apr 18, 2012)8-K (Apr 16, 2012)8-K (Apr 12, 2012)8-K (Mar 22, 2012)8-K (Mar 21, 2012)8-K (Mar 14, 2012)8-K (Feb 17, 2012)8-K (Jan 24, 2012)8-K (Jan 3, 2012)8-K (Dec 21, 2011)8-K (Dec 16, 2011)8-K (Dec 12, 2011)8-K (Nov 29, 2011)8-K (Nov 14, 2011)8-K (Nov 8, 2011)8-K (Oct 25, 2011)8-K (Oct 20, 2011)8-K (Oct 13, 2011)8-K (Oct 11, 2011)8-K (Oct 4, 2011)8-K (Sep 12, 2011)8-K (Sep 6, 2011)8-K (Aug 24, 2011)8-K (Aug 19, 2011)8-K (Aug 10, 2011)8-K (Jul 19, 2011)8-K (Jul 15, 2011)8-K (Jun 29, 2011)8-K (Jun 9, 2011)8-K (Jun 3, 2011)8-K (May 10, 2011)8-K (May 5, 2011)8-K (May 3, 2011)8-K (Apr 12, 2011)8-K (Apr 6, 2011)8-K (Apr 5, 2011)8-K (Mar 22, 2011)8-K (Mar 15, 2011)8-K (Mar 4, 2011)8-K (Feb 14, 2011)8-K (Jan 28, 2011)8-K (Jan 10, 2011)8-K (Jan 3, 2011)8-K (Dec 22, 2010)8-K (Dec 9, 2010)8-K (Dec 3, 2010)8-K (Nov 29, 2010)8-K (Nov 15, 2010)8-K (Nov 10, 2010)8-K (Nov 4, 2010)8-K (Nov 3, 2010)8-K (Oct 26, 2010)8-K (Oct 22, 2010)8-K (Oct 19, 2010)8-K (Oct 14, 2010)8-K (Oct 12, 2010)8-K (Sep 13, 2010)8-K (Sep 9, 2010)8-K (Aug 26, 2010)8-K (Aug 20, 2010)8-K (Aug 17, 2010)8-K (Jul 21, 2010)8-K (Jul 16, 2010)8-K (Jul 7, 2010)8-K (Jun 18, 2010)8-K (Jun 14, 2010)8-K (Jun 11, 2010)8-K (Jun 9, 2010)8-K (May 27, 2010)8-K (May 10, 2010)8-K (May 5, 2010)8-K (May 3, 2010)8-K (Apr 29, 2010)8-K (Mar 16, 2010)8-K (Mar 10, 2010)8-K (Jan 7, 2010)8-K (Jan 6, 2010)8-K (Nov 25, 2009)8-K (Oct 23, 2009)8-K (Oct 20, 2009)8-K (Oct 16, 2009)8-K (Sep 23, 2009)8-K (Aug 25, 2009)8-K (Aug 17, 2009)8-K (Aug 5, 2009)8-K (Jul 13, 2009)8-K (Jul 9, 2009)8-K (Jul 7, 2009)8-K (May 14, 2009)8-K (May 8, 2009)8-K (Apr 30, 2009)8-K (Apr 17, 2009)8-K (Mar 30, 2009)8-K (Feb 27, 2009)8-K (Feb 12, 2009)8-K (Jan 21, 2009)8-K (Nov 21, 2008)8-K (Nov 20, 2008)8-K (Sep 12, 2008)8-K (Sep 11, 2008)8-K (Aug 21, 2008)8-K (Aug 15, 2008)8-K (Aug 6, 2008)8-K (Jul 16, 2008)8-K (Jun 27, 2008)8-K (Jun 25, 2008)8-K (May 20, 2008)8-K (Apr 17, 2008)8-K (Apr 16, 2008)8-K (Apr 4, 2008)8-K (Apr 3, 2008)8-K (Mar 10, 2008)8-K (Jan 9, 2008)8-K (Nov 15, 2007)8-K (Nov 6, 2007)8-K (Oct 24, 2007)8-K (Oct 19, 2007)8-K (Oct 12, 2007)8-K (Aug 16, 2007)8-K (Jun 14, 2007)8-K (May 16, 2007)8-K (Apr 19, 2007)8-K (Feb 22, 2007)8-K (Dec 7, 2006)8-K (Aug 17, 2006)8-K (Jun 19, 2006)8-K (Apr 7, 2006)8-K (Mar 30, 2006)8-K (Mar 14, 2006)8-K (Jan 13, 2006)8-K (Dec 20, 2005)8-K (Jul 6, 2005)8-K (Jun 17, 2005)8-K (Apr 27, 2005)8-K (Apr 1, 2005)8-K (Dec 30, 2004)8-K (Dec 23, 2004)8-K (Nov 16, 2004)8-K (Nov 3, 2004)8-K (Aug 13, 2004)8-K (Jul 7, 2004)8-K (Jun 4, 2004)8-K (May 13, 2004)8-K (Jun 26, 2003)8-K (Jan 21, 2003)8-K (Jul 11, 2002)8-K (Jul 26, 2001)8-K (Feb 16, 2001)8-K (Apr 6, 1999)8-K (Apr 24, 1997)

Other

BIOTIME INC 8-K 2012

Documents found in this filing:

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (date of earliest event reported): May 22, 2012

BioTime, Inc.
(Exact name of registrant as specified in its charter)

California

1-12830

94-3127919

(State or other jurisdiction
of incorporation)

(Commission File Number)

(IRS Employer

Identification No.)

1301 Harbor Bay Parkway
Alameda, California 94502
(Address of principal executive offices)

(510) 521-3390
(Registrant's telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

⃞ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
⃞ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
⃞ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
⃞ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Statements made in this Report that are not historical facts may constitute forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those discussed. Such risks and uncertainties include but are not limited to those discussed in this report and in BioTime's other reports filed with the Securities and Exchange Commission. Words such as “expects,” “may,” “will,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates,” and similar expressions identify forward-looking statements.

Section 7 - Regulation FD

Item 7.01 - Regulation FD Disclosure

On May 22, 2012, BioTime, Inc. issued the press release filed as Exhibit 99.1, which is incorporated by reference.

Section 9 - Financial Statements and Exhibits

Item 9.01 - Financial Statements and Exhibits.

Exhibit Number	Description
99.1	Press release dated May 22, 2012.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

			BIOTIME, INC.


Date:	May 22, 2012	By:	/s/ Peter S. Garcia
			Chief Financial Officer

Exhibit Number	Description

99.1	Press release dated May 22, 2012.

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.

Mobile | Advertise | Licensing & Partnerships | Blogger Tools | Jobs

BIOTIME (BTX)

Annual Reports

Quarterly Reports

8-K

Other

Documents found in this filing: